Download | < Back |
21 Nov 2022 | |
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |